Identifying patients likely to be referred for a clinical pharmacist intervention in a family medicine residency-training clinic

2018 ◽  
Vol 2 (2) ◽  
pp. 131-136
Author(s):  
Joseph P. Vande Griend ◽  
Joseph J. Saseen ◽  
Katherine J. Sullivan ◽  
Heather D. Anderson
Keyword(s):  
Family Medicine ◽  
Residency Training ◽  
Clinical Pharmacist ◽  
Pharmacist Intervention ◽  
Family Medicine Residency ◽  
Training Clinic ◽  
Clinical Pharmacist Intervention

scholarly journals Cost-consequence analysis evaluating multifaceted clinical pharmacist intervention targeting patient transitions of care from hospital to primary care

2018 ◽  
Vol 2 (2) ◽  
pp. 123-130 ◽  
Author(s):  
Maja Kjaer Rasmussen ◽  
Lene Vestergaard Ravn-Nielsen ◽  
Marie-Louise Duckert ◽  
Mia Lolk Lund ◽  
Jolene Pilegaard Henriksen ◽  
...  
Keyword(s):  
Primary Care ◽  
Clinical Pharmacist ◽  
Pharmacist Intervention ◽  
Transitions Of Care ◽  
Consequence Analysis ◽  
Cost Consequence ◽  
Clinical Pharmacist Intervention

scholarly journals Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia

2018 ◽  
Vol 18 (1) ◽  
pp. 81 ◽  
Author(s):  
Vina A. Sagita ◽  
Anton Bahtiar ◽  
Retnosari Andrajati
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
General Hospital ◽  
Clinical Pharmacist ◽  
Drug Effects ◽  
Pharmacist Intervention ◽  
Drug Related Problems ◽  
Clinical Problems ◽  
Clinical Pharmacist Intervention

Objectives: This study aimed to evaluate the role of a clinical pharmacist intervention in decreasing subsequent clinical and drug-related problems (DRPs) among coronary heart disease (CHD) inpatients with at least one previous DRP. Methods: This pre-experimental study with a pre-post design was carried out from January to April 2017 among inpatients with at least one previous DRP at a general hospital in Tangerang District, Banten, Indonesia. Clinical and DRPs were documented prospectively by a clinical pharmacist, with DRPs classified using Version 6.2 of the DRP classification scheme of the Pharmaceutical Care Network Europe Foundation. The intervention consisted of a discussion of identified DRPs with physicians, patients, pharmaceutical logistics clerks, nurses and nutritionists. Following this, any subsequent clinical and DRPs were re-identified and further interventions were conducted as necessary. Results: A total of 75 inpatients were included in the study. Pre-intervention, there were 443 DRPs and 202 clinical problems. The most frequent DRPs were adverse drug reactions (52.6%), followed by drug effects (41.8%). Most DRPs were of moderate severity and would have resulted in moderate consequences had the pharmacist not intervened. The interventions resulted in a significant reduction in the number of DRPs, type of DRPs and number of clinical problems (P <0.05 each). Patients with complications were 26.047 times more likely to have no reduction or an increased number of clinical problems compared to patients without complications (P <0.05). Conclusion: Clinical pharmacist interventions were found to reduce subsequent DRPs and clinical problems among CHD patients with at least one previous DRP.

Clinical Pharmacist Intervention to Engage Older Adults in Reducing Use of Alprazolam

2018 ◽  
Vol 33 (12) ◽  
pp. 711-722 ◽  
Author(s):  
Hilary J. Navy ◽  
Linda Weffald ◽  
Thomas Delate ◽  
Rachana J. Patel ◽  
Jennifer P. Dugan
Keyword(s):  
Older Adults ◽  
Clinical Pharmacist ◽  
Pharmacist Intervention ◽  
Clinical Pharmacist Intervention

Use of Histamine2-Receptor Blocking Agents and Sucralfate in a Health Maintenance Organization following Continued Clinical Pharmacist Intervention

1988 ◽  
Vol 22 (6) ◽  
pp. 466-469 ◽  
Author(s):  
Robert A. Mead ◽  
William F. McGhan
Keyword(s):  
Clinical Pharmacist ◽  
Inappropriate Prescribing ◽  
Health Maintenance Organization ◽  
Pharmacist Intervention ◽  
Cost Ratio ◽  
Health Maintenance ◽  
Receptor Blocking ◽  
Blocking Agents ◽  
Clinical Pharmacist Intervention

The effect of continued clinical pharmacist intervention on the proper use of histamine2-receptor blocking agents and sucralfate in a health maintenance organization was studied. New prescriptions written for Cimetidine, famotidine, ranitidine, and sucralfate in January 1986 (preintervention), October 1986 (postintervention), and February 1987 (follow-up), and the medical record of each patient were analyzed for appropriateness using approved criteria. Clinical pharmacist intervention occurred throughout the study. There was a significant decrease (p < 0.005) in the rate of inappropriate prescribing in the postintervention (42.4 percent) and follow-up (48.7 percent) periods versus the preintervention period (81.5 percent), and in the average number of refills authorized per patient in the postintervention (1.2 ± 1.54) and follow-up (1.3 ± 1.00) periods versus the preintervention period (3.0 ± 3.67). There were no significant differences in these areas between the postintervention and follow-up periods (p > 0.05). A benefit-to-cost ratio of 4.3:1 was generated from this study which demonstrated that continued clinical pharmacy interventions can have a positive, cost-effective impact on the proper use of these commonly prescribed medications.

scholarly journals Impact of Clinical Pharmacist Intervention on the Effectiveness of a Rapid Diagnostic Test for Gram-Positive Bacteremia

2016 ◽  
Vol 3 (suppl_1) ◽  
Author(s):  
Sara Revolinski ◽  
J Njeri Wainaina ◽  
Angela Huang ◽  
Mary Beth Graham ◽  
Nathan Ledeboer ◽  
...  
Keyword(s):  
Diagnostic Test ◽  
Rapid Diagnostic Test ◽  
Clinical Pharmacist ◽  
Pharmacist Intervention ◽  
Gram Positive ◽  
Clinical Pharmacist Intervention
Sign in / Sign up

Export Citation Format

Share Document